479 related articles for article (PubMed ID: 26338970)
21. Hematopoietic stem cells are not the direct target of spontaneous leukemic transformation in p18(INK4C)-null reconstituted mice.
Yuan Y; Yu H; Boyer MJ; Song X; Cao S; Shen H; Cheng T
Cancer Res; 2006 Jan; 66(1):343-51. PubMed ID: 16397248
[TBL] [Abstract][Full Text] [Related]
22. STAT5 signaling is required for the efficient induction and maintenance of CML in mice.
Ye D; Wolff N; Li L; Zhang S; Ilaria RL
Blood; 2006 Jun; 107(12):4917-25. PubMed ID: 16522816
[TBL] [Abstract][Full Text] [Related]
23. Stat5 deficiency decreases transcriptional heterogeneity and supports emergence of hematopoietic sub-populations.
Wang Z; Bunting KD
Oncotarget; 2017 Apr; 8(14):22477-22482. PubMed ID: 28390194
[TBL] [Abstract][Full Text] [Related]
24. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
25. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.
Swaminathan S; Huang C; Geng H; Chen Z; Harvey R; Kang H; Ng C; Titz B; Hurtz C; Sadiyah MF; Nowak D; Thoennissen GB; Rand V; Graeber TG; Koeffler HP; Carroll WL; Willman CL; Hall AG; Igarashi K; Melnick A; Müschen M
Nat Med; 2013 Aug; 19(8):1014-22. PubMed ID: 23852341
[TBL] [Abstract][Full Text] [Related]
26. Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins.
Bird GA; Polsky A; Estes P; Hanlon T; Hamilton H; Morton JJ; Gutman J; Jimeno A; Turner BC; Refaeli Y
PLoS One; 2014; 9(8):e105525. PubMed ID: 25170611
[TBL] [Abstract][Full Text] [Related]
27. Hematopoietic transforming potential of activated ras in chimeric mice.
Hawley RG; Fong AZ; Ngan BY; Hawley TS
Oncogene; 1995 Sep; 11(6):1113-23. PubMed ID: 7566971
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
[TBL] [Abstract][Full Text] [Related]
29. Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells.
Bradley HL; Hawley TS; Bunting KD
Blood; 2002 Dec; 100(12):3983-9. PubMed ID: 12393407
[TBL] [Abstract][Full Text] [Related]
30. VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease.
An W; Mohapatra BC; Zutshi N; Bielecki TA; Goez BT; Luan H; Iseka F; Mushtaq I; Storck MD; Band V; Band H
Oncotarget; 2016 Sep; 7(37):59006-59016. PubMed ID: 27449297
[TBL] [Abstract][Full Text] [Related]
31. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein.
Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP
Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471
[TBL] [Abstract][Full Text] [Related]
32. Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis.
Bagislar S; Sabò A; Kress TR; Doni M; Nicoli P; Campaner S; Amati B
Oncotarget; 2016 Oct; 7(41):66398-66415. PubMed ID: 27655694
[TBL] [Abstract][Full Text] [Related]
33. STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2.
Tam WF; Hähnel PS; Schüler A; Lee BH; Okabe R; Zhu N; Pante SV; Raffel G; Mercher T; Wernig G; Bockamp E; Sasca D; Kreft A; Robinson GW; Hennighausen L; Gilliland DG; Kindler T
Cancer Res; 2013 Jan; 73(1):373-84. PubMed ID: 23149921
[TBL] [Abstract][Full Text] [Related]
34. Homeobox genes in hematopoiesis and leukemogenesis.
Shimamoto T; Ohyashiki K; Toyama K; Takeshita K
Int J Hematol; 1998 Jun; 67(4):339-50. PubMed ID: 9695407
[TBL] [Abstract][Full Text] [Related]
35. Signalling input from divergent pathways subverts B cell transformation.
Chan LN; Murakami MA; Robinson ME; Caeser R; Sadras T; Lee J; Cosgun KN; Kume K; Khairnar V; Xiao G; Ahmed MA; Aghania E; Deb G; Hurtz C; Shojaee S; Hong C; Pölönen P; Nix MA; Chen Z; Chen CW; Chen J; Vogt A; Heinäniemi M; Lohi O; Wiita AP; Izraeli S; Geng H; Weinstock DM; Müschen M
Nature; 2020 Jul; 583(7818):845-851. PubMed ID: 32699415
[TBL] [Abstract][Full Text] [Related]
36. Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells.
Jones M; Chase J; Brinkmeier M; Xu J; Weinberg DN; Schira J; Friedman A; Malek S; Grembecka J; Cierpicki T; Dou Y; Camper SA; Maillard I
J Clin Invest; 2015 May; 125(5):2007-20. PubMed ID: 25866973
[TBL] [Abstract][Full Text] [Related]
37. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
[TBL] [Abstract][Full Text] [Related]
38. Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage.
Cain JA; Xiang Z; O'Neal J; Kreisel F; Colson A; Luo H; Hennighausen L; Tomasson MH
Blood; 2007 May; 109(9):3906-14. PubMed ID: 17218386
[TBL] [Abstract][Full Text] [Related]
39. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Schuringa JJ; Wu K; Morrone G; Moore MA
Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
[TBL] [Abstract][Full Text] [Related]
40. STAT5 activation in B-cell acute lymphoblastic leukemia: damned if you do, damned if you don't.
Wang Z; Bunting KD
Cancer Cell Microenviron; 2016; 3(1):. PubMed ID: 26973852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
